Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent developments in pediatric neuro-oncology.

P K Duffner, M E Cohen

    Cancer
    |July 15, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Childhood brain tumors are rare, but advances in treatment have improved survival, especially for medulloblastoma. However, long-term adverse effects require careful monitoring and management.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Erratum.

    Journal of periodontology·2018
    Same author

    Development of health diagnostics based on personalized medical models.

    Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2016
    Same author

    A comprehensive rehabilitation program for chronic patients in a state mental hospital.

    Community mental health journal·2013
    Same author

    Vascular diseases of the brain.

    Bulletin. New England Medical Center Hospital·2010
    Same author

    The electrocardiogram in neurocirculatory asthenia, anxiety neurosis, or effort syndrome.

    American heart journal·2010
    Same author

    Vascular diseases of the brain.

    Bulletin. New England Medical Center Hospital·2010

    Area of Science:

    • Pediatric Oncology
    • Neuro-oncology
    • Cancer Epidemiology

    Background:

    • Childhood brain tumors are the second most common pediatric malignancy in the US.
    • Limited patient numbers in therapeutic trials due to treatment at specialized centers.
    • Survival rates for pediatric brain tumors are generally lower than for other childhood cancers.

    Purpose of the Study:

    • To review histopathologic groupings, incidence, treatment trends, and survival statistics for childhood brain tumors.
    • To highlight treatment advancements and their associated long-term adverse effects.
    • To emphasize the clinical importance of recognizing and managing delayed treatment effects.

    Main Methods:

    • Utilized data from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) registries.

    Related Experiment Videos

  • Analyzed histopathologic classifications, age-specific incidence, treatment modalities, and survival outcomes.
  • Reviewed literature on treatment advances and their long-term consequences.

    • Main Results:

    • Significant survival improvements observed in medulloblastoma due to advances in surgery, radiation, and chemotherapy.
    • Treatment interventions carry risks of long-term adverse effects, including intellectual deficits, endocrine dysfunction, and secondary malignancies.
    • Delayed effects are clinically significant and potentially manageable or preventable.

    Conclusions:

    • While treatment has improved outcomes for some childhood brain tumors like medulloblastoma, long-term adverse effects are a critical concern.
    • Prompt recognition and monitoring of delayed effects are essential for patient care.
    • Careful management of radiation and chemotherapy administration can help mitigate or prevent adverse outcomes.